SHIRE VIROPHARMA INC

Inactive Instrument

Shire Viropharma Inc Stock

Equities

US9282411084

Biotechnology & Medical Research

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Chart Shire Viropharma Inc

Duration

Period

Style

Latest news about Shire Viropharma Inc

Shire PLC : Shire to pay £2.6 billion for rare disease firm ViroPharma	13-11-11	RE
Viropharma Inc : Novartis sells blood transfusion test unit to Grifols for £1.05 billion	13-11-11	RE
Viropharma Inc : Novartis sells blood transfusion test unit to Grifols for $1.7 billion	13-11-11	RE
Shire PLC : Shire ups 2013 forecast after new CEO's 'cost-reset'	13-10-24	RE

Press releases Shire Viropharma Inc

Shire Viropharma : Director/PDMR Share Dealings	15-02-13	PU
Viropharma : Director Share Dealings (39KB PDF)	14-09-30	PU
Viropharma : Elections for Interim Dividend in Respect of the Six Months to June 30, 2014	14-09-01	PU
Viropharma : Updated Rule 2.10 Announcement	14-07-30	PU
Viropharma : Recommended combination of Shire and AbbVie	14-07-18	PU

More press releases

News in other languages on Shire Viropharma Inc

Viropharma Inc : Avec ViroPharma, Shire saisit une rare opportunité - Plus Europe	13-11-12
Wall Street finit en petite hausse, la prudence prévaut	13-11-11
Wall Street finit en petite hausse, la prudence prévaut	13-11-11
Viropharma Inc : Pharmacie-Shire acquiert ViroPharma pour $4,2 mds	13-11-11

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+22.56%	46.71B
IQVIA HOLDINGS INC.	-1.51%	41.52B
LONZA GROUP AG	+48.83%	41.8B
CELLTRION, INC.	-3.42%	29.55B
ICON PUBLIC LIMITED COMPANY	+10.13%	25.78B
ALNYLAM PHARMACEUTICALS, INC.	-20.44%	19.26B
MEDPACE HOLDINGS, INC.	+26.45%	11.98B
BIO-TECHNE CORPORATION	-0.14%	12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.47%	12.08B

Other Biotechnology & Medical Research

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW